Published in J Am Coll Cardiol on January 05, 2016
Reply: Left Atrial Appendage Occlusion Device Societal Overview: The Surgeon's Comment. J Am Coll Cardiol (2016) 0.75
2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview. J Am Coll Cardiol (2015) 2.06
A European training system in cardiothoracic surgery: is it time? Eur J Cardiothorac Surg (2012) 2.89
Aortic no-touch technique makes the difference in off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg (2011) 2.24
A three-dimensional ring annuloplasty for the treatment of tricuspid regurgitation. Ann Thorac Surg (2006) 1.75
Is off-pump superior to conventional coronary artery bypass grafting in diabetic patients with multivessel disease? Eur J Cardiothorac Surg (2010) 1.59
Off-pump coronary bypass grafting is safe and efficient in patients with left main disease and higher EuroScore. Eur J Cardiothorac Surg (2009) 1.49
Negative microbiological results are not mandatory in deep sternal wound infections before wound closure. Eur J Cardiothorac Surg (2012) 1.48
Despite modern off-pump coronary artery bypass grafting women fare worse than men. Interact Cardiovasc Thorac Surg (2010) 1.42
Survival after acute and complete occlusion of left main stem. Asian Cardiovasc Thorac Ann (2010) 1.39
Long-term outcomes of tricuspid valve replacement in the current era. Ann Thorac Surg (2005) 1.31
How good patient blood management leads to excellent outcomes in Jehovah's witness patients undergoing cardiac surgery. Interact Cardiovasc Thorac Surg (2010) 1.26
Extracorporeal membrane oxygenation for acute respiratory distress syndrome: is the configuration mode an important predictor for the outcome? Interact Cardiovasc Thorac Surg (2011) 1.21
Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells. J Am Coll Cardiol (2010) 1.19
Large annuloplasty rings facilitate mitral valve repair in Barlow's disease. Ann Thorac Surg (2006) 1.11
Early and late outcome of cardiac surgery in patients with liver cirrhosis. Liver Transpl (2007) 1.08
Off-the-shelf human decellularized tissue-engineered heart valves in a non-human primate model. Biomaterials (2013) 1.05
Epicardial left atrial appendage clip occlusion also provides the electrical isolation of the left atrial appendage. Interact Cardiovasc Thorac Surg (2012) 1.04
Safe, effective and durable epicardial left atrial appendage clip occlusion in patients with atrial fibrillation undergoing cardiac surgery: first long-term results from a prospective device trial. Eur J Cardiothorac Surg (2013) 0.98
Current management of ischemic mitral regurgitation. Mt Sinai J Med (2005) 0.98
Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata. Eur Heart J (2011) 0.97
Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesth Analg (2011) 0.94
Injectable living marrow stromal cell-based autologous tissue engineered heart valves: first experiences with a one-step intervention in primates. Eur Heart J (2011) 0.93
Real life cardio-thoracic surgery training in Europe: facing the facts. Interact Cardiovasc Thorac Surg (2010) 0.93
The survey on cellular and engineered tissue therapies in Europe in 2011. Tissue Eng Part A (2013) 0.91
The influence of laboratory coagulation tests and clotting factor levels on Rotation Thromboelastometry (ROTEM(R)) during major surgery with hemorrhage. Anesth Analg (2013) 0.91
Epidemiology of stroke after cardiac surgery in the current era. J Thorac Cardiovasc Surg (2007) 0.90
Tissue engineering on matrix: future of autologous tissue replacement. Semin Immunopathol (2011) 0.90
Letter by Salzberg et al regarding article, "Should off-pump coronary artery bypass grafting be abandoned?". Circulation (2014) 0.90
Generator pocket adhesions of cardiac leads: classification and correlation with transvenous lead extraction results. Pacing Clin Electrophysiol (2013) 0.88
Off-pump or on-pump coronary-artery bypass grafting. N Engl J Med (2013) 0.88
Long-term follow-up after minimal invasive direct coronary artery bypass grafting procedure: a multi-factorial retrospective analysis at 1000 patient-years. Interact Cardiovasc Thorac Surg (2009) 0.88
Prenatally engineered autologous amniotic fluid stem cell-based heart valves in the fetal circulation. Biomaterials (2012) 0.87
A new occlusion device: application of the ArtVentive endoluminal occlusion system (EOS)--first in human clinical trial. Cardiovasc Intervent Radiol (2013) 0.86
Stem cells for heart valve regeneration. Swiss Med Wkly (2012) 0.85
Frailty is a predictor of short- and mid-term mortality after elective cardiac surgery independently of age. Interact Cardiovasc Thorac Surg (2014) 0.84
EH-myomesin splice isoform is a novel marker for dilated cardiomyopathy. Basic Res Cardiol (2010) 0.84
Total arterial off-pump surgery provides excellent outcomes and does not compromise complete revascularization. Eur J Cardiothorac Surg (2012) 0.84
Transvenous lead extractions: comparison of laser vs. mechanical approach. Europace (2013) 0.83
Tissue-engineered vascular graft remodeling in a growing lamb model: expression of matrix metalloproteinases. Eur J Cardiothorac Surg (2012) 0.83
Antibody phage display assisted identification of junction plakoglobin as a potential biomarker for atherosclerosis. PLoS One (2012) 0.83
Routine off-pump coronary artery bypass grafting is safe and feasible in high-risk patients with left main disease. Ann Thorac Surg (2010) 0.83
Unusual complication after infective endocarditis: pseudo-aneurysm of the left ventricle. Eur Heart J (2013) 0.82
Excellent outcomes of cardiac surgery in patients infected with HIV in the current era. Clin Infect Dis (2006) 0.81
Off-pump coronary artery bypass is a safe option in patients presenting as emergency. Ann Acad Med Singapore (2010) 0.81
Functionality, growth and accelerated aging of tissue engineered living autologous vascular grafts. Biomaterials (2012) 0.81
Is dilutional coagulopathy induced by different colloids reversible by replacement of fibrinogen and factor XIII concentrates? Anesth Analg (2013) 0.81
Incidence of sternal wound infection after reexploration in the intensive care unit and the use of local gentamycin. Ann Thorac Surg (2012) 0.80
A three-dimensional engineered artery model for in vitro atherosclerosis research. PLoS One (2013) 0.79
Subclavian artery cannulation provides superior outcomes in patients with acute type-A dissection: long-term results of 290 consecutive patients. Swiss Med Wkly (2013) 0.79
Optimal surgical management of severe tricuspid regurgitation in cardiac transplant patients. J Heart Lung Transplant (2006) 0.79
Off-pump surgery for the poor ventricle? Heart Vessels (2011) 0.78
Impact of different surgical strategies on perioperative protein S100β release in elderly patients undergoing coronary artery bypass grafting. Innovations (Phila) (2013) 0.78
How fast does an atrial myxoma grow? Ann Thorac Surg (2006) 0.78
Outcomes and predictors of success of a radiofrequency- or cryothermy-simplified left-sided maze procedure in patients undergoing mitral valve surgery. J Heart Valve Dis (2006) 0.78
Impressive combination of multiple sinus valsalvae and coronary aneurysms due to hypereosinophilic syndrome. Ann Thorac Surg (2010) 0.77
HEARTSTRING enabled no-touch proximal anastomosis for off-pump coronary artery bypass grafting: current evidence and technique. Interact Cardiovasc Thorac Surg (2013) 0.77
Clampless off-pump surgery reduces stroke in patients with left main disease. Int J Cardiol (2012) 0.77
No association between herpes simplex virus 1 and cardiac myxoma. Swiss Med Wkly (2011) 0.77
Off-pump versus on-pump coronary artery bypass procedures:postoperative renal complications in an Asian population. Ann Acad Med Singapore (2010) 0.77
The potential value of hybrid positron emission tomography/dual-source computed tomography imaging in coronary bypass surgery. Heart Surg Forum (2011) 0.76
Transcatheter direct mitral annuloplasty with Cardioband: feasibility and efficacy trial in an acute preclinical model. EuroIntervention (2016) 0.76
Evaluation of calcium loss after transcatheter aortic valve implantation. Interact Cardiovasc Thorac Surg (2013) 0.76
Severe cardiomyopathy following treatment with the tumour necrosis factor-alpha inhibitor adalimumab for Crohn's disease. Eur J Heart Fail (2009) 0.76
Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation after transcatheter aorticvalve implantation: the surgeon's comment. J Am Coll Cardiol (2012) 0.75
Effects of small pulsed nanocurrents on cell viability in vitro and in vivo: implications for biomedical electrodes. Biomaterials (2010) 0.75
Intramural aortic abscess mimicking chronic aortic dissection. Heart Surg Forum (2012) 0.75
Aneurysm of coronary sinus of Valsalva can rupture anytime! Heart Surg Forum (2011) 0.75
Multimodal characterization of a large right atrial mass after surgical repair of an atrial septal defect. Mt Sinai J Med (2006) 0.75
Left ventricular false aneurysm following percutaneus balloon aortic valvuloplasty: magnetic resonance imaging as diagnostic tool. Eur J Cardiothorac Surg (2006) 0.75
Fifty years of heart transplantation: A journey of courage, innovation and persistence, celebrated in Cape Town. Eur Heart J (2017) 0.75
Off-pump surgery is not a contraindication for patients with a severely decreased ejection fraction. Heart Surg Forum (2011) 0.75
Automatic image segmentation with linear clustering for quantification of neointimal formation after surgical vein grafting. Anal Quant Cytol Histol (2006) 0.75
Managing the Left Atrial Appendage. Eur Heart J (2017) 0.75
Fetal trans-apical stent delivery into the pulmonary artery: prospects for prenatal heart-valve implantation. Eur J Cardiothorac Surg (2011) 0.75
Percutaneous repair of the tricuspid valve using a novel cinching device: acute and chronic experience in a preclinical large animal model. EuroIntervention (2016) 0.75
Acute, subacute, and long-term evaluation of a novel endovascular occlusion system in a large animal model. Catheter Cardiovasc Interv (2014) 0.75
Cell-based cardiac regeneration. Eur Heart J (2017) 0.75
Pre-clinical In Vitro and In Vivo Models for Heart Valve Therapies. J Cardiovasc Transl Res (2015) 0.75
Challenges in translating tissue engineered heart valves into clinical practice. Eur Heart J (2017) 0.75
Sixty-four-slice computed tomographic coronary angiography in pseudoaneurysm of the ascending aorta: a useful modality to supplement the diagnosis. J Thorac Cardiovasc Surg (2006) 0.75
Clot-entrapped blood cells in synergy with human mesenchymal stem cells create a pro-angiogenic healing response. Biomater Sci (2017) 0.75
What happens to functional mitral regurgitation after aortic valve replacement for aortic stenosis? Heart Surg Forum (2013) 0.75
Haemodynamic tracing pattern reveals acute type A aortic dissection. Acute Card Care (2012) 0.75
Huge left-ventricular pseudoaneurysm compressing coronary artery 10 weeks after stabbing attack. Eur Heart J (2013) 0.75
A translational "humanised" porcine model for transcatheter mitral valve interventions: the neo inferior vena cava approach. EuroIntervention (2015) 0.75
Next generation heart valve substitutes. Eur Heart J (2017) 0.75
Surgical management of functional tricuspid regurgitation with a new remodeling annuloplasty ring. Mt Sinai J Med (2006) 0.75